BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 9045892)

  • 1. Contiguous four-guanosine sequence in c-myc antisense phosphorothioate oligonucleotides inhibits cell growth on human lung cancer cells: possible involvement of cell adhesion inhibition.
    Saijo Y; Uchiyama B; Abe T; Satoh K; Nukiwa T
    Jpn J Cancer Res; 1997 Jan; 88(1):26-33. PubMed ID: 9045892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers.
    Chavany C; Connell Y; Neckers L
    Mol Pharmacol; 1995 Oct; 48(4):738-46. PubMed ID: 7476902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer.
    Watson PH; Pon RT; Shiu RP
    Cancer Res; 1991 Aug; 51(15):3996-4000. PubMed ID: 1855215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells.
    Broaddus WC; Chen ZJ; Prabhu SS; Loudon WG; Gillies GT; Phillips LL; Fillmore H
    Neurosurgery; 1997 Oct; 41(4):908-15. PubMed ID: 9316053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combination treatment of c-myc antisense DNA with all-trans-retinoic acid inhibits cell proliferation by downregulating c-myc expression in small cell lung cancer.
    Akie K; Dosaka-Akita H; Murakami A; Kawakami Y
    Antisense Nucleic Acid Drug Dev; 2000 Aug; 10(4):243-9. PubMed ID: 10984118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
    Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
    J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cell adhesion to plastic substratum by phosphorothioate oligonucleotide.
    Watson PH; Pon RT; Shiu RP
    Exp Cell Res; 1992 Oct; 202(2):391-7. PubMed ID: 1397092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism.
    Burgess TL; Fisher EF; Ross SL; Bready JV; Qian YX; Bayewitch LA; Cohen AM; Herrera CJ; Hu SS; Kramer TB
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):4051-5. PubMed ID: 7732029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the proliferative effect of transforming growth factor-alpha by c-myc antisense DNA in human ovarian cancer cells.
    Park HY
    Biochem Mol Biol Int; 1997 Dec; 43(5):1015-22. PubMed ID: 9415810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters.
    Dean NM; McKay R; Condon TP; Bennett CF
    J Biol Chem; 1994 Jun; 269(23):16416-24. PubMed ID: 7911467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular bcr-abl protein levels.
    Smetsers TF; van de Locht LT; Pennings AH; Wessels HM; de Witte TM; Mensink EJ
    Leukemia; 1995 Jan; 9(1):118-30. PubMed ID: 7845006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying c-myc expression in c-myc antisense phosphorothioate oligodeoxynucleotide-treated leukemic and colon cancer cell lines.
    Li BD; Budnick RM; Russo CA; Anderson GR; Stewart CC
    J Surg Res; 1995 Oct; 59(4):485-92. PubMed ID: 7564322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorothioated antisense c-myc oligonucleotide inhibits the growth of human colon carcinoma cells.
    Yu BW; Nguyen D; Anderson S; Allegra CA
    Anticancer Res; 1997; 17(6D):4407-13. PubMed ID: 9494542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative effects of a c-myc antisense oligonucleotide on human arterial smooth muscle cells.
    Ebbecke M; Unterberg C; Buchwald A; Stöhr S; Wiegand V
    Basic Res Cardiol; 1992; 87(6):585-91. PubMed ID: 1485890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense c-myc and immunostimulatory oligonucleotide inhibition of tumorigenesis in a murine B-cell lymphoma transplant model.
    Smith JB; Wickstrom E
    J Natl Cancer Inst; 1998 Aug; 90(15):1146-54. PubMed ID: 9701364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense c-myc effects on preimplantation mouse embryo development.
    Paria BC; Dey SK; Andrews GK
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10051-5. PubMed ID: 1279668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells.
    Shi Y; Hutchinson HG; Hall DJ; Zalewski A
    Circulation; 1993 Sep; 88(3):1190-5. PubMed ID: 8353880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiproliferative effects of antisense oligonucleotides directed to the RNA of c-myc oncogene.
    Degols G; Leonetti JP; Mechti N; Lebleu B
    Nucleic Acids Res; 1991 Feb; 19(4):945-8. PubMed ID: 1708128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense inhibitory effect: a comparison between 3'-partial and full phosphorothioate antisense oligonucleotides.
    Galderisi U; Di Bernardo G; Melone MA; Galano G; Cascino A; Giordano A; Cipollaro M
    J Cell Biochem; 1999 Jul; 74(1):31-7. PubMed ID: 10381259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of cisplatin cytotoxicity on human lung cancer cell lines with N-myc amplification by pretreatment with N-myc antisense oligodeoxynucleotides.
    Mizushima Y; Kashii T; Kobayashi M
    Anticancer Res; 1995; 15(1):37-43. PubMed ID: 7733638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.